Peptide / Material & research guide
ARA290 (Cibinetide)
ARA-290 is also known as cibinetide, an erythropoietin-derived peptide studied separately from full-length erythropoietin.
Catalog specification — select for your inquirySelected: 10 mg × 10 vials
Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.
Material profile
About the material
ARA-290 is also known as cibinetide, an erythropoietin-derived peptide studied separately from full-length erythropoietin.
For ARA290 (Cibinetide), the useful starting point is the material identity—not the broad research category. Compare the complete name and supplied form with the reference used by your laboratory.
Confirm the sequence, terminal groups and assay identity associated with cibinetide. Keep the ARA-290 alias in the request to avoid confusion with the parent protein.
Scientific context
Research context
Research on tissue-response pathways concerns the named peptide and study model. It should not be converted into a claim that this material is erythropoietin or a therapeutic formulation.
Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.
Investigative ophthalmology & visual science · 2017 · PMID 28475703
Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.
Read the primary publication ↗ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice.
Anesthesiology · 2011 · PMID 21873879
Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.
Read the primary publication ↗For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.
Catalog & quotation
Specifications
| Catalog material | ARA290 (Cibinetide) |
|---|---|
| Material class | Peptide |
| Listed options | 10 mg × 10 vials |
| Identity / supplied form | Confirm the sequence, terminal groups and assay identity associated with cibinetide. Keep the ARA-290 alias in the request to avoid confusion with the parent protein. |
| Identity, purity and content | Request the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements. |
| Storage / stability | Follow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed. |
Evidence for the offered material
Documents
Confirm document availability for the actual material and lot. A catalog purity target or packaging label is not a released batch result.
Confirm the sequence, terminal groups and assay identity associated with cibinetide. Keep the ARA-290 alias in the request to avoid confusion with the parent protein.
Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.
Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.
Before you inquire
Questions
Is ARA-290 a full-length erythropoietin product?
Confirm the sequence, terminal groups and assay identity associated with cibinetide. Keep the ARA-290 alias in the request to avoid confusion with the parent protein.
What should my ARA290 (Cibinetide) inquiry include?
Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.
Does the catalog image confirm the selected specification?
No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.
Does a paper or an existing report validate every future batch?
No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.
Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.
Build your ARA290 (Cibinetide) inquiry.
Include the material, amount and evidence your laboratory needs to review.